Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
[High-dose treatment with autologous stem cell support in a Norwegian region].
Tidsskr Nor Laegeforen. 2004 Oct 7;124(19):2498-500.
Tidsskr Nor Laegeforen. 2004.
PMID: 15477890
Free article.
Norwegian.
[Chronic lymphatic leukemia. A population-based study of symptoms, findings, complications and choice of treatment].
Ly B, Hammerstrøm J, Bergheim J, Dahl IM, Grøttum KA, Lødemel B.
Ly B, et al. Among authors: lodemel b.
Tidsskr Nor Laegeforen. 1998 Jan 20;118(2):228-32.
Tidsskr Nor Laegeforen. 1998.
PMID: 9485617
Norwegian.
Item in Clipboard
[Myelodysplastic syndrome and myelogenous leukemia. Treatment with low-dose cytarabine].
Waage A, Hammerstrøm J, Lødemel B, Hoff JE, Langtind J.
Waage A, et al. Among authors: lodemel b.
Tidsskr Nor Laegeforen. 1986 Feb 28;106(6):496-7.
Tidsskr Nor Laegeforen. 1986.
PMID: 3457484
Norwegian.
No abstract available.
Item in Clipboard
[Chronic lymphatic leukemia. Immunophenotyping as an aid to correct diagnosis].
Ly B, Hammerstrøm J, Bergheim J, Dahl IM, Grøttum KA, Lødemel B, Baklien K, Smeland E.
Ly B, et al. Among authors: lodemel b.
Tidsskr Nor Laegeforen. 1998 Jan 20;118(2):233-7.
Tidsskr Nor Laegeforen. 1998.
PMID: 9485618
Norwegian.
Item in Clipboard
Effect of alteplase on the CT hyperdense artery sign and outcome after ischemic stroke.
Mair G, von Kummer R, Morris Z, von Heijne A, Bradey N, Cala L, Peeters A, Farrall AJ, Adami A, Potter G, Cohen G, Sandercock PA, Lindley RI, Wardlaw JM; IST-3 Collaborative Group.
Mair G, et al.
Neurology. 2016 Jan 12;86(2):118-25. doi: 10.1212/WNL.0000000000002236. Epub 2015 Dec 9.
Neurology. 2016.
PMID: 26658907
Free PMC article.
Clinical Trial.
Item in Clipboard
The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.
IST-3 collaborative group; Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G, Innes K, Venables G, Czlonkowska A, Kobayashi A, Ricci S, Murray V, Berge E, Slot KB, Hankey GJ, Correia M, Peeters A, Matz K, Lyrer P, Gubitz G, Phillips SJ, Arauz A.
IST-3 collaborative group, et al.
Lancet. 2012 Jun 23;379(9834):2352-63. doi: 10.1016/S0140-6736(12)60768-5. Epub 2012 May 23.
Lancet. 2012.
PMID: 22632908
Free PMC article.
Clinical Trial.
Item in Clipboard
Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited.
Sandercock P, Lindley R, Wardlaw J, Dennis M, Innes K, Cohen G, Whiteley W, Perry D, Soosay V, Buchanan D, Venables G, Czlonkowska A, Kobayashi A, Berge E, Slot KB, Murray V, Peeters A, Hankey GJ, Matz K, Brainin M, Ricci S, Cantisani TA, Gubitz G, Phillips SJ, Antonio A, Correia M, Lyrer P, Kane I, Lundstrom E; IST-3 collaborative group.
Sandercock P, et al.
Trials. 2011 Nov 30;12:252. doi: 10.1186/1745-6215-12-252.
Trials. 2011.
PMID: 22129158
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite